| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From Medizinische Klinik I (P.J.K., S.H., J.S., S.R., K.H., J.W., G.E.), Cardiovascular Center and Department of Pathology (A.M.), University Wuerzburg, Germany; Division of Cardiology (P.L.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Peter J. Kuhlencordt, MD, University Hospital Wuerzburg, Department of Medicine, Josef Schneider Str. 2, D97080 Wuerzburg, Germany. E-mail kuhlencord_p{at}klink.uni-wuerzburg.de
Objective All 3 isoforms of the nitric oxide synthase (NOS) are expressed in atherosclerotic lesions. To test whether neuronal NOS (nNOS) deficiency affects atherosclerosis, we studied apoE/nNOS
double knockout (DKO) and apolipoprotein E (apoE) knockout (KO) control mice.
Methods and Results Lesion area was significantly increased in male DKO (66%) mice after 14 weeks and in female DKO animals (31%) after 24 weeks of "western" diet. Moreover, mean arterial blood pressure was significantly reduced in female DKO animals. Immunohistochemistry revealed nNOS expression in the neointima of KO mice. In DKO animals, residual nNOS staining was caused by the presence of nNOS splice variants. Whereas nNOS
was present in vessels of KO and absent in DKO animals, nNOS
was expressed in KO and DKO mice.
Conclusion nNOS
protects against atherosclerosis as nNOS
deletion leads to an increase in plaque formation in apoE/nNOS
DKO mice. Female DKO mice showed a significant reduction in mean arterial blood pressure. Additionally, we found expression of nNOS splice variants in vessels of apoE KO mice. Our data highlights nNOS
overexpression as a potential therapeutic strategy and naturally occurring splice variants that lack exon 2 of the nNOS gene as a potential risk factor for vascular disease.
Here we test whether neuronal NOS (nNOS) deficiency affects atherosclerosis in apoE/nNOS
double knockout (DKO) and apoE knockout animals. Male and female DKO animals showed a significant increase in lesion-area. Thus, nNOS
protects against atherosclerosis. Female but not male DKO mice showed a significant reduction in mean arterial blood pressure.
Key Words: nitric oxide nitric oxide synthase arteriosclerosis blood pressure gene expression
Related Article:
Arterioscler Thromb Vasc Biol 2006 26: 1417-1418.
This article has been cited by other articles:
![]() |
G. Lim, L. Venetucci, D. A. Eisner, and B. Casadei Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation-contraction coupling Cardiovasc Res, January 15, 2008; 77(2): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W.T. Liu and P. L. Huang Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice Cardiovasc Res, January 1, 2008; 77(1): 19 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakata, M. Tsutsui, H. Shimokawa, T. Yamashita, A. Tanimoto, H. Tasaki, K. Ozumi, K. Sabanai, T. Morishita, O. Suda, et al. Statin Treatment Upregulates Vascular Neuronal Nitric Oxide Synthase Through Akt/NF-{kappa}B Pathway Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lowenstein Beneficial effects of neuronal nitric oxide synthase in atherosclerosis. Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1417 - 1418. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |